KPTI Price Targets and Analyst Ratings NASDAQ:KPTI
KPTI Forecast. What You Should Know.
KPTI Historical Ratings and Targets
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezo... KPTI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.